These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 23900345)

  • 1. Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting.
    Pan Y; He B; Lirong Z; Nie Z; Chen L; Gu L; Hoffman AR; Wang S; Hu J
    Oncol Rep; 2013 Oct; 30(4):1814-22. PubMed ID: 23900345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system.
    Nie ZL; Pan YQ; He BS; Gu L; Chen LP; Li R; Xu YQ; Gao TY; Song GQ; Hoffman AR; Wang SK; Hu JF
    Mol Cancer; 2012 Nov; 11():86. PubMed ID: 23171475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
    Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin-like growth factor 2 imprinting.
    Sun H; Pan Y; He B; Deng Q; Li R; Xu Y; Chen J; Gao T; Ying H; Wang F; Liu X; Wang S
    Int J Oncol; 2015 Apr; 46(4):1759-67. PubMed ID: 25625919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted tumor gene therapy based on loss of IGF2 imprinting.
    Pan Y; He B; Li T; Zhu C; Zhang L; Wang B; Xu Y; Qu L; Hoffman AR; Wang S; Hu J
    Cancer Biol Ther; 2010 Aug; 10(3):290-8. PubMed ID: 20592487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system.
    Pan Y; He B; Chen J; Sun H; Deng Q; Wang F; Ying H; Liu X; Lin K; Peng H; Xie H; Wang S
    Int J Oncol; 2015 Nov; 47(5):1881-9. PubMed ID: 26397886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
    Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
    Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
    Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
    Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.
    Tian F; Tang Z; Song G; Pan Y; He B; Bao Q; Wang S
    Mol Med Rep; 2012 Jun; 5(6):1536-40. PubMed ID: 22427002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
    Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
    Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific relationship of S-adenosylhomocysteine with allele-specific H19/Igf2 methylation and imprinting in mice with hyperhomocysteinemia.
    Glier MB; Ngai YF; Sulistyoningrum DC; Aleliunas RE; Bottiglieri T; Devlin AM
    Epigenetics; 2013 Jan; 8(1):44-53. PubMed ID: 23221482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions.
    Ishizaki T; Yoshie M; Yaginuma Y; Tanaka T; Ogawa K
    J Biol Chem; 2003 Feb; 278(8):6222-8. PubMed ID: 12475990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of long noncoding RNA H19 rescues hippocampal neurons from apoptosis and oxidative stress by inhibiting IGF2 methylation in mice with streptozotocin-induced diabetes mellitus.
    Yu JL; Li C; Che LH; Zhao YH; Guo YB
    J Cell Physiol; 2019 Jul; 234(7):10655-10670. PubMed ID: 30536889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T; He B; Pan Y; Gu L; Chen L; Nie Z; Xu Y; Li R; Wang S
    Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2.
    Braunschweig MH; Owczarek-Lipska M; Stahlberger-Saitbekova N
    BMC Genet; 2011 May; 12():47. PubMed ID: 21575277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells.
    Gailhouste L; Liew LC; Yasukawa K; Hatada I; Tanaka Y; Kato T; Nakagama H; Ochiya T
    Cell Death Dis; 2019 Jul; 10(8):553. PubMed ID: 31320614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
    Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
    Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
    Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
    Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.
    Sellers ZP; Schneider G; Maj M; Ratajczak MZ
    Stem Cell Rev Rep; 2018 Dec; 14(6):823-836. PubMed ID: 29980981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.